Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

BMTs that are "half-matched" are effective in treating severe sickle cell disease.

2.

Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News.

3.

Aspirin for CRC Risk Reduction May Benefit Unhealthy People Most

4.

Waiting for a Sharp Increase in Prostate Cancer Cases.

5.

Prostate cancer Q&A: Improving detection and reducing overtreatment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot